BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 25135991)

  • 1. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.
    Kollmannsberger C; Tandstad T; Bedard PL; Cohn-Cedermark G; Chung PW; Jewett MA; Powles T; Warde PR; Daneshmand S; Protheroe A; Tyldesley S; Black PC; Chi K; So AI; Moore MJ; Nichols CR
    J Clin Oncol; 2015 Jan; 33(1):51-7. PubMed ID: 25135991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
    Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
    J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
    Boormans JL; Sylvester R; Anson-Cartwright L; Glicksman RM; Hamilton RJ; Hahn E; Daugaard G; Lauritsen J; Wagner T; Avuzzi B; Nicolai N; Del Muro XG; Aparicio J; Stalder O; Rothermundt C; Fischer S; Laguna MP
    Eur Urol Oncol; 2024 Jun; 7(3):537-543. PubMed ID: 37951820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late Relapses in Stage I Testicular Cancer Patients on Surveillance.
    Mortensen MS; Lauritsen J; Kier MG; Bandak M; Appelt AL; Agerbæk M; Holm NV; Kempel MM; von der Maase H; Daugaard G
    Eur Urol; 2016 Aug; 70(2):365-71. PubMed ID: 26996661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations.
    Conduit C; Lewin J; Weickhardt A; Lynam J; Wong S; Grimison P; Sengupta S; Pranavan G; Parnis F; Bastick P; Campbell D; Hansen AR; Leonard M; McJannett M; Stockler MR; Gibbs P; Toner G; Davis ID; Tran B; Kuchel A
    JCO Oncol Pract; 2023 Nov; 19(11):973-980. PubMed ID: 37327464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients.
    Kamba T; Kamoto T; Okubo K; Teramukai S; Kakehi Y; Matsuda T; Ogawa O
    Int J Urol; 2010 Dec; 17(12):980-7. PubMed ID: 20955354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
    Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
    Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
    Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
    Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer.
    Nayan M; Jewett MA; Hosni A; Anson-Cartwright L; Bedard PL; Moore M; Hansen AR; Chung P; Warde P; Sweet J; O'Malley M; Atenafu EG; Hamilton RJ
    Eur Urol; 2017 Jan; 71(1):120-127. PubMed ID: 27527805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance following orchiectomy for stage I testicular seminoma: long-term outcome.
    Yoshida T; Kakimoto K; Takezawa K; Arai Y; Ono Y; Meguro N; Kinouchi T; Nishimura K; Usami M
    Int J Urol; 2009 Sep; 16(9):756-9. PubMed ID: 19659679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance in stage I testicular cancer.
    Daugaard G; Petersen PM; Rørth M
    APMIS; 2003 Jan; 111(1):76-83; discussion 83-5. PubMed ID: 12752240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
    Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
    J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
    Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
    Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatments for stage I testicular cancer.
    Nappi L; Nichols CR; Kollmannsberger CK
    Clin Adv Hematol Oncol; 2017 Aug; 15(8):626-631. PubMed ID: 28949950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.
    Dieckmann KP; Albers P; Classen J; De Wit M; Pichlmeier U; Rick O; Müllerleile U; Kuczyk M
    J Urol; 2005 Mar; 173(3):824-9. PubMed ID: 15711278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.